Traws Pharma, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $22.7M | $43.6M |
| FY2015 | — | $10.0M | $19.8M |
| FY2016 | — | $4.3M | $21.4M |
| FY2017 | — | $-11.7M | $4.0M |
| FY2018 | — | $5.4M | $17.0M |
| FY2019 | — | $11.6M | $22.7M |
| FY2020 | — | $6.2M | $32.0M |
| FY2021 | — | $46.1M | $55.1M |
| FY2022 | — | $28.3M | $38.5M |
| FY2023 | — | $10.7M | $20.6M |